相关实验视频
Updated: Jan 16, 2026

09:43
Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters
Published on: August 22, 2014
15.7K
多价金属核酸纳米激活剂扩大癌症的先天免疫激活金属免疫疗法
Yanjuan Huang1,2, Yike Li1,2, Ziwei Han1,2
1Beijing Engineering Research Center for BioNanotechnology, CAS Key Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing 100190, China.
Nano letters
|October 3, 2025
概括
研究人员开发了新型金属核酸纳米激活剂 (Mn-MNAs),以促进癌症免疫疗法. 这些纳米激素剂通过激活关键途径来增强免疫反应,显示出显著的瘤抑制和改善的治疗疗效.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 金属免疫疗法利用金属离子治疗癌症,但金属离子和激动剂的低生物可用性限制了有效性.
- 对抗瘤免疫反应的强有力的刺激对于有效的癌症免疫治疗至关重要.
研究的目的:
- 开发多价金属核酸纳米激活剂 (Mn-MNAs) 以提高免疫激活剂的稳定性和细胞吸收.
- 通过同时激活干扰素基因 (STING) 和收费类受体9 (TLR9) 途径的刺激器来增强抗瘤免疫力.
主要方法:
- 通过与Fe2+和Mn2+的基于核酸的先天性免疫激动剂的水性协调合成Mn-MNA.
- 评估了Mn-MNAs,以提高激动剂的稳定性和细胞吸收.
- 评估了Mn-MNAs对STING和TLR9通路的激活.
- 在CT26和B16F10瘤模型中分别测试了瘤内和静脉注射Mn-MNAs.
主要成果:
- Mn-MNAs表现出增强的稳定性和免疫激动剂的细胞吸收.
- 通过Mn-MNAs实现了STING和TLR9通路的同时激活.
- 在CT26模型中,内注射Mn-MNAs显著抑制了瘤生长.
- 静脉注射Mn-MNAs在B16F10黑色素瘤模型中显示出显著的疗效,在检查点阻塞下进一步改善.
结论:
- 多价金属核酸纳米激活剂代表了增强癌症免疫疗法的有前途战略.
- Mn-MNAs提供了一种新的方法来克服生物可用性限制并放大抗瘤免疫力.
- 这项工作为癌症金属免疫疗法开发开辟了新的途径.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K

